ORPHENADRINE CITRATE

Orphenadrine Citrate Overview

Orphenadrine citrate is a prescription skeletal muscle relaxant. Doctors prescribe it as an adjunct therapy alongside rest, physical therapy, and other measures to relieve discomfort associated with acute, painful musculoskeletal conditions.

Key Facts Summary:

What Is Orphenadrine Citrate and How Does It Work?

Orphenadrine citrate is a single active ingredient medicine closely related structurally to diphenhydramine.

Mechanism of Action

Unlike some muscle relaxants that act directly on skeletal muscle tissue, Orphenadrine does not relax tense skeletal muscles directly. Instead, it works within the central nervous system (brain and spinal cord).

Orphenadrine acts as a central anticholinergic agent, blocking specific muscarinic acetylcholine receptors in the brain. It also acts as an NMDA receptor antagonist and possesses antihistaminic properties. By suppressing motor nerve pathways and pain perception centers in the brain, it helps break the pain-spasm-pain cycle, relieving muscle stiffness and discomfort.

Is Orphenadrine Citrate FDA Approved?

Yes, Orphenadrine citrate is officially approved by the United States Food and Drug Administration.

What Is Orphenadrine Citrate Used For?

• Adjunct treatment to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.

Before Taking Orphenadrine Citrate: Contraindications and Precautions

Because Orphenadrine possesses potent anticholinergic properties, it carries strict contraindications for several common health conditions.

Who Should Not Take Orphenadrine Citrate?

• Anyone with narrow-angle glaucoma.
• Patients with pyloric or duodenal obstruction, stenosing peptic ulcers, or prostatic hypertrophy (enlarged prostate).
• Patients with obstruction of the bladder neck or cardiospasm (achalasia).
• Anyone with myasthenia gravis.
• Anyone with a known hypersensitivity or severe allergic reaction to Orphenadrine citrate.

Orphenadrine Citrate, Pregnancy and Fertility

Discuss pregnancy plans with your doctor. Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus. It is unknown whether Orphenadrine passes into human breast milk. Discuss breastfeeding risks with your provider.

Tell Your Doctor Before Taking Orphenadrine Citrate

• Disclose any history of heart disease, cardiac arrhythmias, or tachycardia (fast heart rate).
• Inform your provider if you have a history of kidney or liver impairment.
• Share if you have a history of drug abuse or mental health conditions.
• Provide a complete list of all medications you take, especially other anticholinergic drugs, sedatives, or CNS depressants.

Orphenadrine Citrate Dosage and Administration

Orphenadrine citrate is available as a 100 mg oral extended-release tablet or as an injectable solution (30 mg/mL) for IV or IM administration in clinical settings.

Standard Orphenadrine Citrate Dosing

• Oral Extended-Release Tablets: The typical dose for adults is 100 mg taken twice daily (one tablet in the morning and one tablet in the evening).
• Injection: 60 mg (2 mL) given intravenously or intramuscularly every 12 hours as needed.

How Orphenadrine Citrate Is Administered

• Oral Tablets: Swallow extended-release tablets whole with water. Do not crush, chew, break, or dissolve the tablets, as doing so releases the full dose at once and increases toxicity risks.
• Injection: Intravenous or intramuscular injections are administered by a healthcare professional in a clinic or hospital setting.

Orphenadrine Citrate Clinical Efficacy and Research

In clinical trials and observational studies evaluating acute musculoskeletal disorders (such as acute lower back strain or neck spasticity), central muscle relaxants including Orphenadrine demonstrated significant reductions in muscle pain scores and improvements in functional mobility compared to placebo when combined with standard supportive care (rest and physical therapy).

Orphenadrine Citrate Side Effects and Safety Profile

Side effects are primarily driven by Orphenadrine’s strong anticholinergic action across body systems.

Common Orphenadrine Citrate Side Effects

• Dry mouth.
• Drowsiness, dizziness, or lightheadedness.
• Blurred vision or dilated pupils (mydriasis).
• Nausea or vomiting.
• Urinary hesitancy or retention.
• Constipation.
• Tachycardia (fast heartbeat) or palpitations.

Serious Orphenadrine Citrate Adverse Events

• Anticholinergic Toxicity: High doses or sensitivity can lead to severe confusion, anxiety, hallucinations, tremor, urinary retention, and dangerous rapid heart rate.
• CNS Depression and Impairment: Marked drowsiness, dizziness, and motor impairment.
• Cardiac Arrhythmias: Severe tachycardia or palpitations, particularly in patients with underlying heart conditions.
• Dependence and Abuse: Physical dependence and abuse potential have been reported with long-term high-dose use.

Managing Orphenadrine Citrate Side Effects

To manage dry mouth, suck on sugarless hard candy or sip water frequently. If you feel dizzy or lightheaded, sit or lie down immediately and avoid sudden standing movements. If you experience inability to urinate, severe eye pain, or rapid heart rate, seek immediate medical attention.

Orphenadrine Citrate Drug Interactions and What to Avoid

Combining Orphenadrine with other CNS depressants or anticholinergics creates significant additive side effect risks.

Orphenadrine Citrate Drug-Drug Interactions

• CNS Depressants and Alcohol: Combining Orphenadrine with alcohol, benzodiazepines, opioids, or sleeping aids drastically increases drowsiness, sedation, and respiratory depression.
• Other Anticholinergic Drugs: Taking Orphenadrine alongside antihistamines, tricyclic antidepressants, or Parkinson drugs with anticholinergic effects enhances toxicity risks (dry mouth, urinary retention, delirium).
• Phenothiazines: Concurrent use with phenothiazines may result in reduced phenothiazine effect or additive anticholinergic adverse effects.

Orphenadrine Citrate, Food and Alcohol

• Strictly avoid alcohol while taking Orphenadrine, as alcohol significantly increases central nervous system depression and dizziness.
• Tablets may be taken with or without food.

Orphenadrine Citrate Missed Dose, Overdose and Storage

Proper storage and exact adherence to extended-release dosing schedules are vital to avoid accidental overdose.

Missed Dose of Orphenadrine Citrate

If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. Skip the missed dose and return to your regular schedule. Do not double up on doses to make up for a missed tablet.

Orphenadrine Citrate Overdose and Emergency

An overdose of Orphenadrine is rapid and can be life-threatening. Symptoms include severe dry mouth, dilated pupils, rapid heartbeat, confusion, hallucinations, seizures, and coma. Seek emergency medical attention or call Poison Control immediately.

How to Store Orphenadrine Citrate

• Store extended-release tablets at room temperature between 68°F and 77°F (20°C and 25°C).
• Keep the bottle tightly closed in a dry place protected from light and moisture.
• Keep out of reach of children.

Orphenadrine Citrate Patient Management and Monitoring

Routine monitoring ensures safety, particularly in older adults or patients with underlying organ dysfunction.

Tests Before Starting Orphenadrine Citrate

• Baseline screening for cardiovascular risk factors, glaucoma, or bladder outlet obstruction.
• Review of active medication lists for anticholinergic burden.

Monitoring During Orphenadrine Citrate Treatment

• Assessment of symptom relief and duration of therapy (therapy should be short-term).
• Monitoring for signs of anticholinergic toxicity (mental changes, urinary retention, severe constipation).
• Periodic liver and kidney function tests during prolonged use.

Orphenadrine Citrate Do’s and Don’ts

• DO swallow extended-release tablets whole.
• DO exercise caution when getting up from a sitting or lying position to prevent falls.
• DON’T drive, operate machinery, or perform hazardous tasks until you know how this medicine affects you.
• DON’T consume alcohol or take over-the-counter sleep aids while on this treatment.

Frequently Asked Questions

References

• U.S. FDA prescribing information for Orphenadrine Citrate extended-release tablets
• U.S. FDA Drugs@FDA drug approval overview (Application No. 012157)
• American Society of Health-System Pharmacists (ASHP) Drug Information for Muscle Relaxants

Legal Disclaimer

The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.